RMEBX
Price
$61.85
Change
+$0.16 (+0.26%)
Updated
Oct 17 closing price
Net Assets
110.88B
SLVCX
Price
$18.12
Change
+$0.08 (+0.44%)
Updated
Oct 17 closing price
Net Assets
17.61M
Interact to see
Advertisement

RMEBX vs SLVCX

Header iconRMEBX vs SLVCX Comparison
Open Charts RMEBX vs SLVCXBanner chart's image
American Funds American Mutual R2E
Price$61.85
Change+$0.16 (+0.26%)
VolumeN/A
Net Assets110.88B
Saratoga Large Capitalization Value C
Price$18.12
Change+$0.08 (+0.44%)
VolumeN/A
Net Assets17.61M
RMEBX vs SLVCX Comparison Chart in %
View a ticker or compare two or three
VS
RMEBX vs. SLVCX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMEBX is a Buy and SLVCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 111B vs. SLVCX (17.6M). RMEBX pays higher dividends than SLVCX: RMEBX (1.05) vs SLVCX (0.00). RMEBX was incepted earlier than SLVCX: RMEBX (11 years) vs SLVCX (27 years). SLVCX (2.87) is less costly to investors than RMEBX (1.07). SLVCX is a more actively managed with annual turnover of: 83.00 vs. RMEBX (31.00). RMEBX (250) and SLVCX (250) have matching initial minimum investment requirements. RMEBX annual gain was more profitable for investors over the last year : 4.81 vs. SLVCX (-14.45). RMEBX return over 5 years is better than : 55.95 vs. SLVCX (0.33).
RMEBXSLVCXRMEBX / SLVCX
Total Expense Ratio1.072.8737%
Annual Report Gross Expense Ratio1.072.8737%
Fund Existence11 years27 years-
Gain YTD13.52710.488129%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets111B17.6M630,682%
Annual Yield % from dividends1.050.00-
Returns for 1 year4.81-14.45-33%
Returns for 3 years38.192.031,884%
Returns for 5 years55.950.3316,839%
Returns for 10 years89.361.406,387%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NNNN29.001.28
+4.62%
Anbio Biotechnology
SPGI473.191.14
+0.24%
S&P Global
GATX172.02-2.41
-1.38%
GATX Corp
NMRA1.73-0.05
-2.81%
Neumora Therapeutics
MYO1.03-0.05
-4.63%
Myomo